Environmental Impact Acquisition Stock News

Environmental Impact Acquisition Corp. (NASDAQ:ENVI) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 107,900 shares, a growth of 41.0% from the November 15th total of 76,500 shares. Based on an average daily trading volume, of 106,300 shares, the days-to-cover ratio is presently []

Environmental Impact Acquisition (NASDAQ:ENVI) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Earnings and Valuation This table compares Environmental Impact Acquisition and Twist Biosciences gross revenue, earnings []

Environmental Impact Acquisition (NASDAQ:ENVI) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Earnings & Valuation This table compares Environmental Impact Acquisition and Twist Biosciences top-line revenue, earnings [] The post Environmental Impact Acquisition (NASDAQ:ENVI) & Twist Bioscience (NASDAQ:TWST) Head-To-Head Comparison appeared first on ETF Daily News .

Citadel Advisors LLC trimmed its holdings in Environmental Impact Acquisition Corp. (OTCMKTS:ENVIU) by 3.4% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 319,026 shares of the companys stock after selling 11,167 shares during the quarter. Citadel Advisors LLCs holdings in Environmental Impact Acquisition were worth $3,286,000 as of its most recent filing with []

Millennium Management LLC boosted its holdings in Environmental Impact Acquisition Corp. (OTCMKTS:ENVIU) by 9.0% during the second quarter, HoldingsChannel.com reports. The fund owned 360,560 shares of the companys stock after acquiring an additional 29,917 shares during the period. Millennium Management LLCs holdings in Environmental Impact Acquisition were worth $3,732,000 as of its most recent filing []

The partnership will help advance GreenLight''s messenger RNA COVID-19 vaccine candidate, in support of ongoing global health needs. BOSTON and INCHEON, South Korea , Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services, announced a partnership agreement in which Samsung Biologics will manufacture GreenLight''s messenger RNA COVID-19 vaccine candidate at commercial scale. GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing The partnership aims to accelerate production of GreenLight''s COVID-19 vaccine candidate for Phase III clinical trials and, subject to regulatory approval, commercial sales.

Goldman Sachs Group Inc. grew its position in Environmental Impact Acquisition Corp. (NASDAQ:ENVI) by 143.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 333,889 shares of the communications equipment providers stock after acquiring an additional 196,489 shares during the quarter. Goldman Sachs Group []

Get Rich And Save The Earth With ESG SPAC Climate II